Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm (PAR) - First Ross River Trial Participant Treated

Aug 9, 2017 at 3:42 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment